| DIR: /home/aissorg/mail/.spam/new /home/aissorg/mail/.spam/new/ |
| Current File : /home/aissorg/mail/.spam/new/1748698041.M88620P3987966.v22437909.sin01.serveradd.com,S=5060,W=5155 |
Return-Path: <coes@co-es.com.mx>
Delivered-To: aissorg+spam@v22437909.sin01.serveradd.com
Received: from v22437909.sin01.serveradd.com
by v22437909.sin01.serveradd.com with LMTP
id zuLTBLkDO2j+2TwA+povcg
(envelope-from <coes@co-es.com.mx>)
for <aissorg+spam@v22437909.sin01.serveradd.com>; Sat, 31 May 2025 09:27:21 -0400
Return-path: <coes@co-es.com.mx>
Envelope-to: evexpo@aiss.org.in
Delivery-date: Sat, 31 May 2025 09:27:21 -0400
Received: from dedicadow16.servidoreswindows.com ([209.236.114.164]:63257)
by v22437909.sin01.serveradd.com with esmtp (Exim 4.98.1)
(envelope-from <coes@co-es.com.mx>)
id 1uLMF4-0000000GjRa-1uXv
for evexpo@aiss.org.in;
Sat, 31 May 2025 09:27:21 -0400
Received: from co-es.com.mx (23-94-177-36-host.colocrossing.com [23.94.177.36]) by dedicadow16.servidoreswindows.com with SMTP;
Sat, 31 May 2025 07:26:24 -0600
Reply-To: paulantony516@yandex.com
From: "Dr. Paul" <coes@co-es.com.mx>
To: evexpo@aiss.org.in
Date: 31 May 2025 15:26:25 +0200
Message-ID: <20250531152625.0E089891BE40AF41@co-es.com.mx>
MIME-Version: 1.0
Content-Type: text/html
Content-Transfer-Encoding: quoted-printable
X-Spam-Status: Yes, score=5.3
X-Spam-Score: 53
X-Spam-Bar: +++++
X-Spam-Report: Spam detection software, running on the system "v22437909.sin01.serveradd.com",
has identified this incoming email as possible spam. The original
message has been attached to this so you can view it or label
similar future email. If you have any questions, see
root\@localhost for details.
Content preview: Dear Sir, My name is Dr. Paul, a research & procurement consultant
with one of the leading indigenous multi-million-pound pharmaceutical companies
in the United Kingdom, a major manufacturer of Biopharmaceutica [...]
Content analysis details: (5.3 points, 5.0 required)
pts rule name description
---- ---------------------- --------------------------------------------------
0.0 RCVD_IN_VALIDITY_CERTIFIED_BLOCKED RBL: ADMINISTRATOR NOTICE: The
query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[209.236.114.164 listed in sa-trusted.bondedsender.org]
0.0 KAM_DMARC_STATUS Test Rule for DKIM or SPF Failure with Strict
Alignment
1.7 DEAR_SOMETHING BODY: Contains 'Dear (something)'
0.2 FREEMAIL_REPLYTO_END_DIGIT Reply-To freemail username ends in digit
[paulantony516(at)yandex.com]
0.0 HTML_MESSAGE BODY: HTML included in message
0.1 MIME_HTML_ONLY BODY: Message only has text/html MIME parts
0.0 RCVD_IN_VALIDITY_SAFE_BLOCKED RBL: ADMINISTRATOR NOTICE: The query to
Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[209.236.114.164 listed in sa-accredit.habeas.com]
0.0 RCVD_IN_VALIDITY_RPBL_BLOCKED RBL: ADMINISTRATOR NOTICE: The query to
Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[209.236.114.164 listed in bl.score.senderscore.com]
1.0 KAM_LAZY_DOMAIN_SECURITY Sending domain does not have any
anti-forgery methods
0.5 KAM_NUMSUBJECT Subject ends in numbers excluding current years
1.8 FREEMAIL_FORGED_REPLYTO Freemail in Reply-To, but not From
X-Spam-Flag: YES
Subject: BUSINESS TO PARTNER - Opportunity for urgent Supply - 2025
<!DOCTYPE HTML>
<html><head><title></title>
<meta http-equiv=3D"X-UA-Compatible" content=3D"IE=3Dedge">
</head>
<body style=3D"margin: 0.4em;"><p>Dear Sir,<br></p><p>My name is Dr. Paul, =
a research & procurement consultant with one
of the leading indigenous multi-million-pound pharmaceutical companies=20
in the United Kingdom, a major manufacturer of Biopharmaceuticals=20
products, Coronavirus vaccines and various life saving antiviral and=20
retrovirus vaccines, Healthcare consumables, Supplements and Cancer=20
treatment.<br><br>I need your participation to procure and supply a major R=
aw Material that my company uses
for production, and you may eventually become my company's next permanent =
global supplier. My company=20
purchases this major Raw Material in large quantities and needs this p=
roduct
urgently to commence a commercial production of some new anti-viral dr=
ugs=20
and vaccines. <br><br>This may not be your area of specialization, but it w=
ill=20
be another income generating business out of your specialty.<br>
<br>Upon receipt of your interest, I can share more details of this lifetim=
e opportunity for your review and consideration.<br>I await your response.<=
br><br>Sincerely,<br>Dr. Paul.</p></body></html>
|